Who should be considered for monoclonal antibody or antiviral therapy? Your medical history, risks, and symptoms will help your healthcare provider determine if this treatment is necessary to ease your risk of serious complications due to a COVID-19 infection. These antibodies make it more difficult for the virus to reproduce in your body and cause harm. Monoclonal antibodies are made in a laboratory and are given to patients directly with an infusion. Naturally our bodies produce antibodies to fight infection. What are monoclonal antibodies and how do they work? Monoclonal Antibody TreatmentsĬOVID-19 monoclonal antibody therapeutics (mAb) are available for people ages 12 years or older that have a positive COVID-19 test along with the high risk of becoming seriously ill. These treatment options are by doctor prescription only. Your medical history, risks, and symptoms will help your healthcare provider determine which drug might be best to help ease your risk of serious complications due to a COVID-19 infection.

Where can I gain access to antiviral drugs? They should be taken within the first 5 days of feeling symptoms. Both medications are to be used by high-risk people.

Paxlovid and molnupiravir are the first oral medications to be approved for treating mild to moderate COVID-19. In Clinical trials showed that Paxlovidhad a 88% reduction in hospitalizations/deaths whereas Molnupiravir had a 30% reduction in hospitalizations/deaths.

These drugs can ease symptoms and shorten the length of a viral infection like COVID-1 What are the differences between Paxlovid and Molnupiravir?īoth are two oral antiviral treatments that are authorized to treat mild/moderate COVID-19. Out-of-Hospital Options for COVID-19 Treatment Oral Antiviral TreatmentsĪntiviral medications are those which help the body fight off viruses.

Rapid covid testing shelby township